Filter Results :

Your search for Hematological returned 11 reports

Sort by


Hematological Tumor Global Clinical Trials Review, H1, 2015

16 Mar 2015  |  Published by:  GlobalData
Summary“Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their re...

$ 2,500.00

Read More

Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

21 Jan 2015  |  Published by:  MP Advisors
While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations in cancerous cells that ...

$ 3,000.00
$ 2,700.00
( Save 10% )

Read More

Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

01 Jan 2015  |  Published by:  DelveInsight
Summary Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and...

$ 3,000.00

Read More

Other Hematological Disorders-Pipeline Insights, 2015

07 Aug 2014  |  Published by:  DelveInsight
SUMMARY'Other Hematological Disorders-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Other Hematological Disorders. This report p...

$ 1,250.00

Read More

Hematological Tumor - Pipeline Review, H1 2014

30 Jun 2014  |  Published by:  Global Markets Direct
Summary‘Hematological Tumor - Pipeline Review, H1 2014’, provides an overview of the Hematological Tumor’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hematological Tumor, complete with comparative analysis at various stages, therapeutics as...

$ 2,000.00

Read More

Treating Refractory Hematological Malignancies

22 Feb 2014  |  Published by:  MP Advisors
Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs – Thalomid (thalidomide) and Revlimid (...

$ 2,500.00

Read More

Treating Refractory Hematological Malignancies - Multiple Myeloma (MM): New Treatment Options Driving In-Licensing and M&A

13 Sep 2013  |  Published by:  MP Advisors
The report provides an overview of the therapies for Multiple Myeloma (Newly diagnosed - NDMM and relapsed/ refractory - RRMM), unmet need, and limitations of the current standard of care (SoC) for relapsed and refractory MM pts. The report highlights the competition and commercial opportunity...

$ 2,500.00

Read More

Treating Refractory Hematological Malignancies - Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML): Emerging Therapeutics

29 Aug 2013  |  Published by:  MP Advisors
The report provides an overview of the approved therapies for AML, MDS, unmet need and limitations of the current SOC for relapsed and refractory pts. The report highlights the competition and commercial opportunity in pursuing this therapy area – Comprehensive list of the early and late stage...

$ 2,500.00

Read More

Other Hematological Disorders - Pipeline Review, H1 2013

28 Mar 2013  |  Published by:  Global Markets Direct
Summary'Other Hematological Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Hematological Disorders, complete with latest updates, and special features on late-stage and di...

$ 2,000.00

Read More

Drugs and Diagnostics for Hematological Disorders: Global Markets

06 Mar 2013  |  Published by:  BCC Research
REPORT HIGHLIGHTS This report provides: -An overview of the global market for drugs and diagnostics for hematological disorders.-Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.-A breakdown of the market...

$ 6,650.00

Read More

Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis In Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines And Disposable Kits)

27 Feb 2013  |  Published by:  Transparency Market Research
Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis In Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines And Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018This report on the global...

$ 4,595.00

Read More
Total 11 records.